{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:27:21Z","timestamp":1723336041435},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,10]]},"DOI":"10.7759\/cureus.66592","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T18:06:47Z","timestamp":1723313207000},"source":"Crossref","is-referenced-by-count":0,"title":["Polymyalgia Rheumatica Complicated by Nephrotic Syndrome in a Nonagenarian: A Case Report"],"prefix":"10.7759","author":[{"given":"Ayato","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23132","article-title":"Epidemiology of polymyalgia rheumatica 2000-2014 and examination of incidence and survival trends over 45 years: a population-based study","volume":"69","author":"Raheel S","year":"2017","unstructured":"Raheel S, Shbeeb I, Crowson CS, Matteson EL. Epidemiology of polymyalgia rheumatica 2000-2014 and examination of incidence and survival trends over 45 years: a population-based study. Arthritis Care Res (Hoboken). 2017, 69:1282-5. 10.1002\/acr.23132","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.12242","article-title":"Polymyalgia rheumatica: an update (review)","volume":"26","author":"Florescu MM","year":"2023","unstructured":"Florescu MM, Bobirc\u0103 F, Florescu A, et al.. Polymyalgia rheumatica: an update (review). Exp Ther Med. 2023, 26:543. 10.3892\/etm.2023.12242","journal-title":"Exp Ther Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.142","article-title":"Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities","volume":"13","author":"Dejaco C","year":"2017","unstructured":"Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol. 2017, 13:578-92. 10.1038\/nrrheum.2017.142","journal-title":"Nat Rev Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3265\/Nefrologia.pre2012.Jun.11574","article-title":"Minimal change nephropathy in a patient with polymyalgia rheumatica","volume":"32","author":"Heras M","year":"2012","unstructured":"Heras M, Saiz A, Fern\u00e1ndez-Reyes MJ, S\u00e1nchez R, Molina A, Rodr\u00edguez MA. Minimal change nephropathy in a patient with polymyalgia rheumatica. Nefrologia. 2012, 32:692-3. 10.3265\/Nefrologia.pre2012.Jun.11574","journal-title":"Nefrologia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.07.005","article-title":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Sharma A","year":"2020","unstructured":"Sharma A, Mohammad AJ, Turesson C. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum. 2020, 50:1040-8. 10.1016\/j.semarthrit.2020.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000345280","article-title":"A case of diffuse endocapillary proliferative glomerulonephritis associated with polymyalgia rheumatica","volume":"2","author":"Takeshima E","year":"2012","unstructured":"Takeshima E, Morishita Y, Ogura M, et al.. A case of diffuse endocapillary proliferative glomerulonephritis associated with polymyalgia rheumatica. Case Rep Nephrol Urol. 2012, 2:158-64. 10.1159\/000345280","journal-title":"Case Rep Nephrol Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-6686.2010.00200.x","article-title":"Rapid development of renal failure secondary to AA-type amyloidosis in a patient with polymyalgia rheumatica","volume":"36","author":"Javaid MM","year":"2010","unstructured":"Javaid MM, Kamalanathan M, Kon SP. Rapid development of renal failure secondary to AA-type amyloidosis in a patient with polymyalgia rheumatica. J Ren Care. 2010, 36:199-202. 10.1111\/j.1755-6686.2010.00200.x","journal-title":"J Ren Care"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201810001-01486","article-title":"A case of secondary amyloidosis in a patient with well-controlled polymyalgia rheumatica: 1486","volume":"113","author":"Owen S","year":"2018","unstructured":"Owen S, Coss E, Klazynski B. A case of secondary amyloidosis in a patient with well-controlled polymyalgia rheumatica: 1486. Am J Gastroenterol. 2018, 113:S853.","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70312-X","article-title":"Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica","volume":"35","author":"Escrib\u00e1 A","year":"2000","unstructured":"Escrib\u00e1 A, Morales E, Albiz\u00faa E, et al.. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica. Am J Kidney Dis. 2000, 35:137-40. 10.1016\/S0272-6386(00)70312-X","journal-title":"Am J Kidney Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.44.1009","article-title":"Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica","volume":"44","author":"Shimojima Y","year":"2005","unstructured":"Shimojima Y, Matsuda M, Gono T, Ishii W, Ikeda S. Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica. Intern Med. 2005, 44:1009-12. 10.2169\/internalmedicine.44.1009","journal-title":"Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1144397","article-title":"Case report: rapid development of amyloid A amyloidosis in temporal arteritis with SAA1.3 allele; an unusual case of intestinal amyloidosis secondary to temporal arteritis","volume":"14","author":"Yoshida S","year":"2023","unstructured":"Yoshida S, Matsumoto H, Temmoku J, et al.. Case report: rapid development of amyloid A amyloidosis in temporal arteritis with SAA1.3 allele; an unusual case of intestinal amyloidosis secondary to temporal arteritis. Front Immunol. 2023, 14:1144397. 10.3389\/fimmu.2023.1144397","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000305","article-title":"Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?","volume":"2","author":"Toussirot \u00c9","year":"2016","unstructured":"Toussirot \u00c9, R\u00e9gent A, Devauchelle-Pensec V, Saraux A, Pu\u00e9chal X. Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?. RMD Open. 2016, 2:e000305. 10.1136\/rmdopen-2016-000305","journal-title":"RMD Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.10165.1","article-title":"Recent advances in understanding and treating nephrotic syndrome","volume":"6","author":"Bierzynska A","year":"2017","unstructured":"Bierzynska A, Saleem M. Recent advances in understanding and treating nephrotic syndrome. F1000Res. 2017, 6:121. 10.12688\/f1000research.10165.1","journal-title":"F1000Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20031789","article-title":"Differentiating between seronegative elderly-onset rheumatoid arthritis and polymyalgia rheumatica: a qualitative synthesis of narrative reviews","volume":"20","author":"Ohta R","year":"2023","unstructured":"Ohta R, Sano C. Differentiating between seronegative elderly-onset rheumatoid arthritis and polymyalgia rheumatica: a qualitative synthesis of narrative reviews. Int J Environ Res Public Health. 2023, 20:1789. 10.3390\/ijerph20031789","journal-title":"Int J Environ Res Public Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55088","article-title":"Frailty syndrome in rural communities: a narrative review and interviews with rural individuals","volume":"16","author":"Ohta R","year":"2024","unstructured":"Ohta R, Yakabe T, Sano C. Frailty syndrome in rural communities: a narrative review and interviews with rural individuals. Cureus. 2024, 16:e55088. 10.7759\/cureus.55088","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-019-1197-9","article-title":"Factors associated with frequent use of emergency-department services in a geriatric population: a systematic review","volume":"19","author":"Dufour I","year":"2019","unstructured":"Dufour I, Chouinard MC, Dubuc N, Beaudin J, Lafontaine S, Hudon C. Factors associated with frequent use of emergency-department services in a geriatric population: a systematic review. BMC Geriatr. 2019, 19:185. 10.1186\/s12877-019-1197-9","journal-title":"BMC Geriatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42514","article-title":"Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome initially diagnosed as fibromyalgia: a case report","volume":"15","author":"Ohta R","year":"2023","unstructured":"Ohta R, Sano C. Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome initially diagnosed as fibromyalgia: a case report. Cureus. 2023, 15:e42514. 10.7759\/cureus.42514","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S89465","article-title":"Multiple myeloma in the very elderly patient: challenges and solutions","volume":"11","author":"Willan J","year":"2016","unstructured":"Willan J, Eyre TA, Sharpley F, Watson C, King AJ, Ramasamy K. Multiple myeloma in the very elderly patient: challenges and solutions. Clin Interv Aging. 2016, 11:423-35. 10.2147\/CIA.S89465","journal-title":"Clin Interv Aging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30811","article-title":"Family physicians as system-specific specialists in Japan's aging society","volume":"14","author":"Ohta R","year":"2022","unstructured":"Ohta R, Sano C. Family physicians as system-specific specialists in Japan's aging society. Cureus. 2022, 14:e30811. 10.7759\/cureus.30811","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-024-00392-9","article-title":"Factors affecting the duration of initial medical care seeking among older rural patients diagnosed with rheumatoid arthritis: a retrospective cohort study","volume":"8","author":"Ohta R","year":"2024","unstructured":"Ohta R, Sano C. Factors affecting the duration of initial medical care seeking among older rural patients diagnosed with rheumatoid arthritis: a retrospective cohort study. BMC Rheumatol. 2024, 8:23. 10.1186\/s41927-024-00392-9","journal-title":"BMC Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280449-polymyalgia-rheumatica-complicated-by-nephrotic-syndrome-in-a-nonagenarian-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T18:06:52Z","timestamp":1723313212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280449-polymyalgia-rheumatica-complicated-by-nephrotic-syndrome-in-a-nonagenarian-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.66592","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,10]]}}}